Anda di halaman 1dari 3

DAFTAR PUSTAKA

1. Rivers E, Nouyen B., Havstad S. Early goal-directed therapy in the treatment


of severe sepsis an septic shock. N Engl J Med. 2001; 345(19): 1368-76.
2. Pohan H.T. Penanganan sepsis secara paripurna. Acta Medica Indosiana.
2003. Vol. XXXV (suppl 1) : S19-23.
3. Dellinger RP., Carlet JM., Masur H., Gerlach H., Calandra T., Cohen J., et al.
Surviving sepsis campaign guidelines for management of severe sepsis and
septic shock. Critical Care Medicine 2004 Vol. 32, No. 3: 858-873.
4. Syaroni A. Pendekatan dalam penatalaksanaan sepsis. Makalah Lengkap
Konferensi Kerja V PERALMUNI, Palembang 2003 Lembaga Penerbit
Bagian Ilmu Penyakit Dalam FK UNSRI/RSMH Palembang. 2003: 83-88.
5. Sofwan, Rudianto. Prokalsitonin sebagai kandidat petanda inflamasi pada
sepsis neonatorum. Jakarta : Damianus Journal of medicine.2010. Vol.9.No.1:
38-44.
6. Hermawan AG. Pendekatan patobiologi reaksi inflamasi pada sepsis.
Kumpulan Makalah Lengkap Kongres Nasional PETRI XI, PERPARI VII,
PKWI VIII, PIT II PAPDI Cabang Surakarta. Solo. UNS Press.2005.
Halaman: 91-96.
7. Assicot M., Gendrel D., Carsin H., Raymond J., Guilbaud J.,Bohuon C., High
serum procalcitonin concentrations in patients with sepsis and infection.
Lancet,
1993, 41:515518.
8. Wheeler AP., Bernard GR. Treating Patient with severe Sepsis. New English
Medical Journal 340,3 p207-214, November 2004.
9. OConnor EO., Venkatesh B., Lipman J., Mashongonyika C., Hall J.
Procalcitonin in critical ilness. Crit Care Res 2001;3:236-243.
10. Whang KT., Steinwald PM., White JC., Nylen ES., Snider RH., Simon GL, et
45

46

al, Serum Calcitonin in precursor in sepsis and sytemic inflamation. J Clin


Endocrinol Metab. 1998.83(9); 3296-302.
11. Buchori, Prihatini. Diagnosis Sepsis menggunakan prokalsitonin. Indonesian
Jurnal of

Clinical Pathology and Medical Laboratory. Surabaya Juli

2006.Vol 12. No 3. Hal.127-133.


12. Surgical infection. Dalam: Brunicardi FC, Andersen DK, Billiar TR, et al
editor. Schwartzs Principles of Surgery, 9th ed. Mc Graw Hill. 2010, 223-69.
13. Meisner, Michael. Pathobiochemistry and clinical use of procalcitonin.
Jerman : Clinica chimica acta. 2002. Vol.323:17-29.
14. Bohuon C. Biochemistry of the calcitonin gene : Discovery of procalcitonin
as a remarkable marker of bacterial disseases,new data and trends,2002.
Hal.2-3.
15. Hatheril M. Diagnostic Markers of infection : comparison of procalcitonin
with C reactive protein and leucocyte count. Arch Dis Child.1999. 81 : 417421.
16. Leclerc F. Procalcitonin as prognostic marker in children with meningococcal
septic shock. Arch Dis Child. 2002, 87-450.
17. Karlsson, Sari. Predictive Value of Procalcitonin Decrease in Patients with
Severe Sepsis : A Prospective Observational Study. 2010. Biomedical
journal.
18. Soreng, Katherine. Procalcitonin : an Emerging Biomarker of bacterial sepsis.
2011. Los Angeles. Clinical Microbiology newsletter.
19. Ahmadinejad, Zahra. Evaluation of Serum Procalcitonin in Patients with
Systemic Inflamatory Response Syndrome with and without Infection. Acta
medica Iranica.2009;47(50383-388).
20. Jawetz E, Melnick JL, Adelberg EA, Brooks GF, Batel JS, Ornston LN.
Prinsip-prinsip mikrobioogi kedokteran diagnostik.Mikrobiologi kedokteran.
Jakarta : EGC, 2001: 415-30.

47

21. Miller JM, Berttina B, Wentworth, editors. Methods for quality control in
Diagnostic microbiology. Washington DC: American Public Health
Association. 1985.
22. Khoshdell, Abolfazl. Sensitivitas dan spesifitas procalcitonin pada diagnosis
sepsis neonatorum. Teheran : Iranian Journal of Pathology. 2008. Vol.3. No.
4: 203-207.
23. Riedel, Stefan. Procalcitonin as Marker for the detection of Bacteremia and
Sepsis is the Emergency department. Baltimore : American Journal of
Clinical Pathology. 2011. Vol.135. 182-18.
24.

Dellinger RP., Carlet JM., Masur H., Gerlach H., Calandra T., Cohen J., et

al. Surviving Sepsis Campaign : International guideline for management of


severe sepsis and septic shock. Critical Care Medicine. 2008. Vol. 36; 29632.